Article Versions Notes

Eisenga MF, De Jong MA, Leaf DE, Nolte IM, De Borst MH, Bakker SJL, Gaillard CAJM. Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation. Journal of Clinical Medicine. 2020; 9(6):1737. https://doi.org/10.3390/jcm9061737

Eisenga, Michele F., Maarten A. De Jong, David E. Leaf, Ilja M. Nolte, Martin H. De Borst, Stephan J. L. Bakker, and Carlo A. J. M. Gaillard. 2020. "Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation" Journal of Clinical Medicine 9, no. 6: 1737. https://doi.org/10.3390/jcm9061737

Eisenga, M. F., De Jong, M. A., Leaf, D. E., Nolte, I. M., De Borst, M. H., Bakker, S. J. L., & Gaillard, C. A. J. M. (2020). Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation. Journal of Clinical Medicine, 9(6), 1737. https://doi.org/10.3390/jcm9061737